Showing results (51-60 of 264) with videos related to

Sort By:
Pageof 27
Current Opinion in Infectious Diseases|September 28, 2021
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infectionsMatteo Bassetti, Daniele Roberto Giacobbe, Nadia Castaldo, et al.
Expert Review of Anti-Infective Therapy|February 17, 2021
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteriaAlessandro Russo, Marco Berruti, Daniele Roberto Giacobbe, et al.
Current Opinion in Infectious Diseases|January 9, 2025
Omadacycline for the treatment of skin and soft tissue infectionsAntonio Vena, Nadia Castaldo, Daniele Roberto Giacobbe, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 21, 2022
New antibiotics for Gram-negative pneumoniaMatteo Bassetti, Federica Magnè, Daniele Roberto Giacobbe, et al.
Expert Opinion on Pharmacotherapy|October 13, 2025
Investigating cefepime/taniborbactam for the treatment of complicated urinary tract infectionsClaudia Bartalucci, Marianna Giurco, Antonio Vena, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 9, 2025
Candida endocarditis: current perspectives on diagnosis and therapyRonen Ben-Ami, Matteo Bassetti, Emilio Bouza, et al.
Antibiotics (Basel, Switzerland)|October 27, 2022
Fidaxomicin for the Treatment of Clostridioides difficile Infection in Adult Patients: An Update on Results from Randomized Controlled TrialsDaniele Roberto Giacobbe, Antonio Vena, Marco Falcone, et al.
Studies in Health Technology and Informatics|November 23, 2020
Reuse of Clinical COVID-19 Patient Data: Pre-Processing for Future ClassificationElena Lazarova, Sara Mora, Antonio Di Biagio, et al.
Expert Opinion on Pharmacotherapy|September 11, 2020
Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspectiveMatteo Bassetti, Laura Labate, Chiara Russo, et al.
Current Opinion in Infectious Diseases|October 16, 2020
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?Matteo Bassetti, Daniele R Giacobbe, Chiara Robba, et al.
Pageof 27